Dec. 3 at 1:47 AM
$MXCT The Enterprise Value at today's closing price is around
$15 Million.
That is absurdly cheap, in my view - especially considering the depth and breadth of their 32 SPL agreements and core business that is potentially bottoming out this year, and returning to growth in the second half of next year.
I almost wonder if they are going to announce a "shareholders rights plan" aka poison pill to prevent a hostile takeover.
The shares are trading at a discount to book value, and anyone with deep pockets would be buying a cash-rich company that has numerous shots on goal, with a royalty stream from Casgevy revenues starting to advance.
This seems like such an extreme valuation mismatch.
I am heavily long at ~1.43
